KAZIA THERAPEUTICS LTD(KZIA)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

KAZIA THERAPEUTICS LTD (KZIA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores KZIA at 29.3/100 on a 32-signal composite quality model, placing it at rank #2,532 of 2,962 stocks — the bottom half of the AI-ranked universe. Top institutional holders of KZIA by reported 13-F value include Boxer Capital Management, FLPUTNAM INVESTMENT MANAGEMENT, Bleichroeder, based on the most recent SEC filings. KZIA trades on the Nasdaq exchange and files with the SEC under CIK 1075880. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate KZIA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for KAZIA THERAPEUTICS LTD directly from SEC EDGAR.

AI Quality Score

29.3/100

AI Rank

#2,532

KZIA key financials by period

KAZIA THERAPEUTICS LTD reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodFormRevenueNet incomeOperating margin
FY 202520-F$42.0K——
FY 202420-F$2.3M——
FY 201820-F$119.0K——
FY 201720-F$249.0K——
FY 201620-F$406.0K——

Institutions holding KZIA

Institutional investors reporting a position in KAZIA THERAPEUTICS LTD on SEC Form 13F.
InstitutionSharesValueReported
Boxer Capital Management560,000$7.9M2026-06-30
FLPUTNAM INVESTMENT MANAGEMENT414,958$5.8M2026-06-30
Bleichroeder400,000$5.6M2026-06-30
Ikarian Capital396,201$5.6M2026-06-30
Dauntless Investment Group354,208$5.0M2026-06-30
Stonepine Capital Management345,179$4.9M2026-06-30
SUSQUEHANNA INTERNATIONAL GROUP, LLP251,700$3.5M2026-06-30
Point72 Asset Management, L.P.200,300$2.3M2026-06-30
Ensign Peak Advisors110,778$1.6M2026-06-30
MILLENNIUM MANAGEMENT101,376$1.4M2026-06-30
SEC EDGAR: CIK 1075880 →
KZIA

KAZIA THERAPEUTICS LTD

KZIA
NasdaqMid CapHealthcare

13F Pro Quality Score

29.3/100

Rank #2,532 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Financial metrics will appear once SEC EDGAR data is ingested for this company.

Top Institutional Holders

as of Q2 2026
$56.36M total
Boxer Capital Management, LLC
$7.88MNew
FLPUTNAM INVESTMENT MANAGEMENT CO
$5.84M+191.3%
Bleichroeder LP
$5.63M0.0%
Ikarian Capital, LLC
$5.58MNew
Dauntless Investment Group, LLC
$4.99M+343.7%
Stonepine Capital Management, LLC
$4.86M0.0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP
$3.54MNew
Point72 Asset Management, L.P.
$2.30M+0.1%
Ensign Peak Advisors, Inc
$1.56MNew
MILLENNIUM MANAGEMENT LLC
$1.43MNew
Loading ratio trend…